Remedium Bio: Funding, Investors & Team (Oct 2026)
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe conditions. Our strategy for product development involves using established technologies in innovative ways to target well-understood disease processes. We aim to simplify our research by incorporating successful elements of technology to create localized treatments that concentrate on proven molecules and pathways. Our current focus is on gene therapy for Rheumatology / Osteoarthritis, Endocrinology / Diabetes, and Neurology / Stroke.
Remedium Bio has raised $13.8M across 5 funding rounds on record, the most recent a Series A of $10.0M announced in Aug 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Remedium Bio Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Remedium Bio Funding Rounds
2 of 5 rounds were announced without a disclosed amount and are excluded from the total.
Remedium Bio raised $2.3M in a Seed announced in Aug 2022.
1 years later, an undisclosed round was announced in Aug 2023 with no disclosed amount.
1.1 years later, a Seed was announced in Sep 2024 with no disclosed amount.
1.7 years later, an undisclosed round of $1.5M was announced in May 2026.
3 months later, a Series A of $10.0M was announced in Aug 2026.
Remedium Bio Investors
12 investors are recorded in total; the 5 named above are those the record identifies.
Remedium Bio Founders and Leadership Team
Contact details for the Remedium Bio team: 3 of 4 have an email address on file, 3 have a LinkedIn profile.
Start 14-day free trial →Remedium Bio Funding Compared to Other Biotechnology Startups
Remedium Bio's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Remedium Bio in Biotechnology and Needham
Companies Similar to Remedium Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Remedium Bio Funding FAQs
What does Remedium Bio do?
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe conditions. Our strategy for product development involves using established technologies in innovative ways to target well-understood disease processes. We aim to simplify our research by incorporating successful elements of technology to create localized treatments that concentrate on proven molecules and pathways. Our current focus is on gene therapy for Rheumatology / Osteoarthritis, Endocrinology / Diabetes, and Neurology / Stroke.
How much funding has Remedium Bio raised?
Remedium Bio has raised $13.8M across 5 rounds on record. The most recent is a Series A of $10.0M announced in Aug 2026.
When did Remedium Bio last raise funding?
Remedium Bio's most recent funding round on record is a Series A of $10.0M, announced in Aug 2026.
Who has invested in Remedium Bio?
Investors on record for Remedium Bio include Eli Lilly, National Science Foundation, Ulu Ventures, MicroVentures, Longevitytech.fund. FundedIQ records 12 investors in total.
Who founded Remedium Bio?
FundedIQ lists Francesco Luppino (Founder), Luppino (Founder) at Remedium Bio.
Who is the CEO of Remedium Bio?
Frank Luppino is listed as CEO at Remedium Bio.
Where is Remedium Bio headquartered?
Remedium Bio is based in Needham, Massachusetts, United States.
How many employees does Remedium Bio have?
Remedium Bio is in the 1-10 employee band.
When was Remedium Bio founded?
Remedium Bio was founded in 2020.
How does Remedium Bio's funding compare to other Biotechnology startups?
Remedium Bio's latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Remedium Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Remedium Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.